Pr François Ghiringhelli

Spécialité

Oncologue médical, expert digestif

Hôpital

Centre Georges-François Leclerc (Dijon)

Derniers articles

• Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy. (10 août 2026)
• Usability and relevance of specialized population-based cancer registry data in externally controlled trials. (5 août 2026)
• Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective. (1 juil. 2026)
• IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy. (22 juin 2026)
• An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy. (16 juin 2026)